| Mr Thomas F Varecka, MD | |
|
2805 Campus Dr, Ste 425, Plymouth, MN 55441-2680 | |
| (763) 383-0770 | |
| (763) 383-0777 |
| Full Name | Mr Thomas F Varecka |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 50 Years |
| Location | 2805 Campus Dr, Plymouth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669478723 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 22452 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hennepin County Medical Center 1 | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tria Orthopaedic Center Llc | 3173570561 | 367 |
| Hennepin Healthcare System Inc | 4789684861 | 794 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
Since the institution of nationwide folic acid fortification of enriched grains in the mid 1990s, the number of infants born in the United States and Canada with neural tube defects has declined by 20 percent to 50 percent.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."
› Verified 5 days ago
| Entity Name | Park Nicollet Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
Since the institution of nationwide folic acid fortification of enriched grains in the mid 1990s, the number of infants born in the United States and Canada with neural tube defects has declined by 20 percent to 50 percent.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."
› Verified 5 days ago
| Entity Name | Hennepin Healthcare System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138136 PECOS PAC ID: 4789684861 Enrollment ID: O20070207000467 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
Since the institution of nationwide folic acid fortification of enriched grains in the mid 1990s, the number of infants born in the United States and Canada with neural tube defects has declined by 20 percent to 50 percent.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."
› Verified 5 days ago
| Entity Name | Tria Orthopaedic Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518273085 PECOS PAC ID: 3173570561 Enrollment ID: O20110310000999 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
Since the institution of nationwide folic acid fortification of enriched grains in the mid 1990s, the number of infants born in the United States and Canada with neural tube defects has declined by 20 percent to 50 percent.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Thomas F Varecka, MD 2805 Campus Dr, Ste 425, Plymouth, MN 55441-2680 Ph: (763) 383-0770 | Mr Thomas F Varecka, MD 2805 Campus Dr, Ste 425, Plymouth, MN 55441-2680 Ph: (763) 383-0770 |
News Archive
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.
Since the institution of nationwide folic acid fortification of enriched grains in the mid 1990s, the number of infants born in the United States and Canada with neural tube defects has declined by 20 percent to 50 percent.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."
› Verified 5 days ago
Richard M Salib, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5904 | |
Tyler R Williamson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 16800 37th Pl N, Ste 200, Plymouth, MN 55446 Phone: 635-207-8707 Fax: 763-520-7580 | |
Dr. Roman Gabriel Guerrero-maestre, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 | |
Dr. Edward Rainier Gamboa Santos, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5904 | |
Andrew Brooks, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5903 | |
Jeffrey S Pinto, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5904 |